Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Breast Cancer Research and Treatment
|
January 9, 2023
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer
Matthew Loft, Sheau Wen Lok, Richard De Boer, et al.
JCO Oncology Practice
|
May 14, 2020
Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic
Eva Segelov, Craig Underhill, Hans Prenen, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 17, 2017
How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?
Lewis Au, Natalie Turner, Hui-Li Wong, et al.
Clinical Breast Cancer
|
August 8, 2022
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study
Iris Tung, Cristina Moldovan, Vanessa Wong, et al.
International Journal of Cancer
|
August 25, 2022
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA)
Sheau Wen Lok, Richard De Boer, Sally Baron-Hay, et al.
Clinical Colorectal Cancer
|
July 22, 2021
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases
Vinod Kalapurackal Mathai, Soe Yu Aung, Vanessa Wong, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 19, 2021
Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population
Sandy Tun Min, Aflah Roohullah, Annette Tognela, et al.
Internal Medicine Journal
|
September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
Christine Semira, Hui-Li Wong, Kathryn Field, et al.
Clinical Breast Cancer
|
September 23, 2022
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer
Vanessa Wong, Richard de Boer, Sally Baron-Hay, et al.
Vaccines
|
September 23, 2022
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers
Nathan Bain, Mike Nguyen, Lisa Grech, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Breast Cancer Research and Treatment
|
January 9, 2023
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer
Matthew Loft, Sheau Wen Lok, Richard De Boer, et al.
JCO Oncology Practice
|
May 14, 2020
Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic
Eva Segelov, Craig Underhill, Hans Prenen, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 17, 2017
How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?
Lewis Au, Natalie Turner, Hui-Li Wong, et al.
Clinical Breast Cancer
|
August 8, 2022
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study
Iris Tung, Cristina Moldovan, Vanessa Wong, et al.
International Journal of Cancer
|
August 25, 2022
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA)
Sheau Wen Lok, Richard De Boer, Sally Baron-Hay, et al.
Clinical Colorectal Cancer
|
July 22, 2021
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases
Vinod Kalapurackal Mathai, Soe Yu Aung, Vanessa Wong, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 19, 2021
Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population
Sandy Tun Min, Aflah Roohullah, Annette Tognela, et al.
Internal Medicine Journal
|
September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
Christine Semira, Hui-Li Wong, Kathryn Field, et al.
Clinical Breast Cancer
|
September 23, 2022
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer
Vanessa Wong, Richard de Boer, Sally Baron-Hay, et al.
Vaccines
|
September 23, 2022
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers
Nathan Bain, Mike Nguyen, Lisa Grech, et al.
Page
of 6